Board Recommends Eliminating Curbs on Pricey Cystic-Fibrosis Drug

An advisory board recommended Wednesday that Arkansas’s Medicaid program eliminate restrictions on the use of an expensive cystic fibrosis drug made by Vertex Pharmaceuticals Inc. that are the subject of a legal battle in federal court.

Members of the state’s Drug Utilization Review Board, which is made up of Arkansas doctors and pharmacists, recommended that the state adopt a revised set of criteria for prescribing the drug, called...